针对三阴性乳腺癌的全身疗法的进展
Roberto A Leon-Ferre1, Matthew P Goetz1
1Department of Oncology, Mayo Clinic, Rochester, MN, USA.
概括
三重阴性乳腺癌 (TNBC) 管理正在随着新的向疗法和抗体药物合物而发展. 本综述涵盖了可操作和转移性TNBC治疗的最新进展,解决了挑战和未来的研究方向.
科学领域:
- 在瘤学瘤学.
- 医学研究 医学研究
背景情况:
- 三阴性乳腺癌 (TNBC) 由于缺乏可向受体,其复发率和死亡率很高.
- 在历史上,治疗一直依赖于细胞毒性化疗,目标治疗选择有限.
研究的目的:
- 审查TNBC的现代管理,专注于可操作的疾病和转移性治疗进展.
- 讨论TNBC治疗的挑战和未来方向,包括免疫疗法和基于生物标志物的方法.
主要方法:
- 审查最近的临床试验数据和TNBC的治疗批准.
- 分析当前的治疗策略和在可操作和转移环境中的新兴研究.
主要成果:
- 新的向疗法和抗体-药物合物正在改善TNBC的结果.
- 新辅助免疫疗法提出了新的治疗范式和实际挑战.
结论:
- 了解TNBC生物学方面的进步正在推动新疗法的发展.
- 未来的研究应该专注于基于生物标志物的治疗优化,早期复发检测和改进转移性疾病管理.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Therapies
7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
Tumor Immunotherapy
577
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
577
Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K


